Pantoprazole Gastro Resistant Tablets Ip 40 MG - PANAQUA 40 Tablets

ANAQUA 40 Tablets – Advanced Acid Control with Dual Release Technology.

PANAQUA 40 Tablets – The composition of Pantoprazole Gastro Resistant Tablets IP 40 MG is a gastro-resistant formulation that enhances stability in acidic environments, ensuring maximum therapeutic effect and prolonged symptom control. It is a proton pump inhibitor (PPI) designed with dual-release technology for rapid and sustained acid suppression.
First Release: Immediate acid neutralization to control acute symptoms.
Second Release: Sustained inhibition of H+/K+ ATPase enzyme, ensuring long-term acid suppression for chronic conditions.

Key Benefits of Pantoprazole 40 MG – PANAQUA 40 Tablets
✅ Dual Release Technology for Prolonged Acid Suppression – Ensures immediate acid control followed by sustained release for 24-hour symptom relief in GERD, peptic ulcers, and Zollinger-Ellison syndrome.
✅ Superior Acid Stability & Bioavailability – The gastro-resistant coating prevents degradation in the stomach, allowing better absorption and efficacy compared to conventional PPIs.
✅ Ideal for Severe & Resistant Acid Disorders – Higher-dose Pantoprazole provides enhanced suppression of gastric acid, beneficial in severe GERD, refractory ulcers, and hypersecretory conditions.

Recommended By Specialists:
👨‍⚕️ Gastroenterologists: Mainly used to treat GERD, peptic ulcers, Zollinger-Ellison syndrome, and erosive esophagitis.
👨‍⚕️ General Physicians: Commonly preferred as first-line therapy for acid reflux, heartburn, gastritis, and indigestion.
👨‍⚕️ Internal Medicine Specialists: Frequently used in patients with chronic acid-peptic disorders, H. pylori treatment regimens, or long-term NSAID therapy.

INDICATIONS:
✅ Severe & Refractory GERD
✅ Erosive Esophagitis
✅ Peptic & Duodenal Ulcers
✅ Zollinger-Ellison Syndrome (Hypersecretory Condition)
✅ NSAID-Induced Gastric Ulcers